ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,594Medicare Part D Prescriptions Filled, Including Refills

Rank: 384 out of 939

$321K Total Retail Price of All Prescriptions

Rank: 446 out of 939

366 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 5,346 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 354 238 1 2
AMLODIPINE BESYLATE 294 200 2 6
OMEPRAZOLE 218 114 3 5
LISINOPRIL 215 129 4 3
METOPROLOL TARTRATE 193 132 5 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 148 6 23
POTASSIUM CHLORIDE 166 145 7 9
LEVOTHYROXINE SODIUM 161 141 8 4
FUROSEMIDE 160 144 9 7
METOPROLOL SUCCINATE 149 119 10 21
METFORMIN HCL 142 110 11 8
MELOXICAM 136 66 12 14
HYDROCODONE-ACETAMINOPHEN 127 59 S3 13 1
HYDROCHLOROTHIAZIDE 122 97 14 12
GLIPIZIDE 122 95 14 52
GABAPENTIN 119 82 16 11
WARFARIN SODIUM 109 104 17 17
TRAMADOL HCL 91 73 18 16
ATENOLOL 91 72 18 19
ATORVASTATIN CALCIUM 83 65 20 22
DIOVAN HCT 82 60 21 74
METFORMIN HCL ER 81 35 22 76
SERTRALINE HCL 80 46 23 24
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78 24 55
NEXIUM 75 42 25 18
CLOPIDOGREL 69 54 26 28
ZOLPIDEM TARTRATE 68 34 27 20
CYCLOBENZAPRINE HCL 65 39 R 28 36
TAMSULOSIN HCL 65 44 28 27
CLONIDINE HCL 62 49 30 39
CITALOPRAM HBR 62 54 30 15
RANITIDINE HCL 59 32 32 35
NIFEDIPINE ER 57 44 33 105
POLYETHYLENE GLYCOL 3350 56 56 34 57
PLAVIX 56 50 34 48
KLOR-CON M20 56 26 34 90
DIGOXIN 55 55 37 45
SPIRIVA 54 44 38 73
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 42 38 64
PRAVASTATIN SODIUM 50 44 40 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.